These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 19176945

  • 1. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
    Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.
    Neuroendocrinology; 2009; 89(4):441-7. PubMed ID: 19176945
    [Abstract] [Full Text] [Related]

  • 2. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 3. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 4. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
    Horm Metab Res; 1992 Mar 18; 24(3):122-6. PubMed ID: 1533604
    [Abstract] [Full Text] [Related]

  • 5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov 18; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 6. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug 18; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty.
    Isaac H, Patel L, Meyer S, Hall CM, Cusick C, Price DA, Clayton PE.
    Horm Res; 2007 Aug 18; 68(4):157-63. PubMed ID: 17356292
    [Abstract] [Full Text] [Related]

  • 8. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 18; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 9. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2002 Jul 18; 39(7):633-9. PubMed ID: 12147888
    [Abstract] [Full Text] [Related]

  • 10. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK, Fan X, Tang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May 18; 11(5):374-6. PubMed ID: 19470261
    [Abstract] [Full Text] [Related]

  • 11. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.
    J Med Assoc Thai; 2001 Jun 18; 84 Suppl 1():S51-6. PubMed ID: 11529380
    [Abstract] [Full Text] [Related]

  • 12. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F, Federico G, Harrell JC, Saggese G.
    Neuroendocrinology; 2009 Jun 18; 90(3):307-14. PubMed ID: 19641297
    [Abstract] [Full Text] [Related]

  • 13. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
    Heger S, Müller M, Ranke M, Schwarz HP, Waldhauser F, Partsch CJ, Sippell WG.
    Mol Cell Endocrinol; 2006 Jul 25; 254-255():217-20. PubMed ID: 16757104
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S, Partsch CJ, Sippell WG.
    J Clin Endocrinol Metab; 1999 Dec 25; 84(12):4583-90. PubMed ID: 10599723
    [Abstract] [Full Text] [Related]

  • 15. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
    Bertelloni S, Mul D.
    Asian J Androl; 2008 Jul 25; 10(4):525-34. PubMed ID: 18478155
    [Abstract] [Full Text] [Related]

  • 16. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F, Hofman PL, Jefferies C, Gunn AJ, Cutfield WS.
    Clin Endocrinol (Oxf); 2009 May 25; 70(5):751-6. PubMed ID: 19178517
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul 25; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 18. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.
    Eur J Pediatr; 1998 May 25; 157(5):363-7. PubMed ID: 9625331
    [Abstract] [Full Text] [Related]

  • 19. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
    Karamizadeh Z, Kashef MA, Jalaeian H, Namazee N.
    Kaohsiung J Med Sci; 2006 Apr 25; 22(4):161-5. PubMed ID: 16679296
    [Abstract] [Full Text] [Related]

  • 20. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
    Palmert MR, Mansfield MJ, Crowley WF, Crigler JF, Crawford JD, Boepple PA.
    J Clin Endocrinol Metab; 1999 Dec 25; 84(12):4480-8. PubMed ID: 10599706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.